featured
Lenvatinib vs Placebo in Radioiodine-Refractory Thyroid Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Lenvatinib Versus Placebo in Radioiodine-Refractory Thyroid Cancer
N. Engl. J. Med 2015 Feb 12;372(7)621-630, M Schlumberger, M Tahara, LJ Wirth, B Robinson, MS Brose, R Elisei, MA Habra, K Newbold, MH Shah, AO Hoff, AG Gianoukakis, N Kiyota, MH Taylor, SB Kim, MK Krzyzanowska, CE Dutcus, B de las Heras, J Zhu, SI ShermanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.